Lei Ma
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility 10
- Pharmacology top 2%
- Cholinesterase and Neurodegenerative Diseases 5
- Antibiotics Pharmacokinetics and Efficacy 5
- Molecular Medicine top 5%
- Epidemiology top 10%
-
- Receptor Mechanisms and Signaling 12
- Pharmacological Receptor Mechanisms and Effects 6
-
- Neuroscience and Neuropharmacology Research 10
-
- Computational Drug Discovery Methods 7
-
- Pharmaceutical studies and practices 5
- Co-authors
- Gopal KrishnaEdward O’MaraMonika MartinhoGeorge L. DrusanoRichard A. PrestonM. MartinhoMarion WittmannMatthew A. Seager
- Partner nations
- United StatesChinaGermany
In The Last Decade
Lei Ma
50 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 93
- Applied Microbiology and Biotechnology 62
- Infectious Diseases 433
- Pharmacology 388
- Molecular Medicine 104
- Epidemiology 452
Countries citing papers authored by Lei Ma
This map shows the geographic impact of Lei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Ma more than expected).
Fields of papers citing papers by Lei Ma
This network shows the impact of papers produced by Lei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Ma. The network helps show where Lei Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lei Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2020 | 5 | |
| 5 | 2018 | 3 | |
| 6 | 2014 | 31 | |
| 7 | 2014 | 7 | |
| 8 | 2011 | 15 | |
| 9 | 2011 | 35 | |
| 10 | 2010 | 25 | |
| 11 | 2010 | 14 | |
| 12 | 2010 | 15 | |
| 13 | 2010 | 21 | |
| 14 | 2010 | 50 | |
| 15 | 2009 | 20 | |
| 16 | 2009 | 23 | |
| 17 | 2009 | 55 | |
| 18 | 2009 | 44 | |
| 19 | 2009 | 40 | |
| 20 | 2002 | 35 |
About Lei Ma
Lei Ma is a scholar working on Applied Microbiology and Biotechnology, Pharmacology and Cellular and Molecular Neuroscience, having authored 52 papers that have together received 1.4k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (12 papers), Antifungal resistance and susceptibility (10 papers), Neuroscience and Neuropharmacology Research (10 papers), Computational Drug Discovery Methods (7 papers), Pharmacological Receptor Mechanisms and Effects (6 papers), Pharmaceutical studies and practices (5 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (62 citations), Infectious Diseases (433 citations) and Pharmacology (388 citations). Lei Ma has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Gopal Krishna, Edward O’Mara, Monika Martinho, George L. Drusano, Richard A. Preston, M. Martinho, Marion Wittmann, Matthew A. Seager, William J. Ray and George D. Hartman.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.